Increased serum levels of Galectin‑9 in patients with chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Increased serum levels of Galectin‑9 in patients with chronic lymphocytic leukemia

Published:2018-11-01 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wdowiak Kamil¹,Gallego‑Colon Enrique²,Francuz Tomasz¹,Czajka‑Francuz Paulina¹,Ruiz‑Agamez Natalia²,Kubeczko Marcin³,Grochoła Iga¹,Wybraniec Maciej⁴,Chudek Jerzy¹,Wojnar Jerzy¹

Affiliation:

1. Department of Internal Medicine and Oncological Chemotherapy, Silesian Medical University, Katowice 40‑027, Poland

2. Department of Biochemistry, Silesian Medical University, Katowice 40‑752, Poland

3. Clinical and Experimental Oncology Department, Maria Skłodowska‑Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice 44‑101, Japan

4. First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice 40‑635, Poland

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating levels of galectin‐9 are a potential biomarker of survival in advanced non‐small‐cell lung cancer;Journal of Surgical Oncology;2024-07-24

2. The expression of Galectin‐9 correlates with mTOR and AMPK in murine colony‐forming erythroid progenitors;European Journal of Haematology;2024-06-10

3. The role of galectins in mediating the adhesion of circulating cells to vascular endothelium;Frontiers in Immunology;2024-05-22

4. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion;Molecular Biology Reports;2024-04-25

5. Integrative multi-omics identifies regulatory and exhausted T cell types and novel immunotherapy targets in CLL lymph nodes;2024-03-29